This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2 S Wild , G Roglic , A Green , R Sicree & H King (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047–1053.
3 RM van Dam , WC Willett , EB Rimm , MJ Stampfer & FB Hu (2002) Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 25, 417–424.
4 JW Baynes & SR Thorpe (1999) Perspectives in diabetes. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes 48, 1–9.
5 JC Pickup (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetres. Diabetes Care 27, 813–823.
7 MC Polidori , P Mecocci , W Stahl , (2000) Plasma level of lypophilic antioxidants in very old patients with type 2 diabetes. Diabetes Metab Res Rev 16, 15–19.
8 MC Polidori , W Stahl , O Eichler , (2001) Profile of antioxidants in human plasma. Free Radic Biol Med 30, 456–462.
9 KD Price , CSC Price & RD Reynolds (2001) Hyperglycemia-induced ascorbic acid deficiency promotes endothelial dysfunction and the development of atherosclerosis. Atherosclerosis 158, 1–12.
10 J Valabhji , AJ McColi , W Richmond , (2001) Antioxidant status and coronary artery calcification in type 1 diabetes. Diabetes Care 24, 1608–1613.
11 PG Pietta (2000) Flavonoids as antioxidant. J Nat Prod 63, 1035–1042.
13 C Noguchi & E Nikki (2000) Phenolic antioxidants. A rationale for design and evaluation of novel antioxidant drugs for atherosclerosis. Free Radic Biol Med 28, 1538–1546.
14 R Clarke & J Armitage (2002) Antioxidant vitamins and risk of cardiovascular disease. Review of large scale randomized trials. Cardiovasc Drugs Ther 16, 411–415.
17 C Manach , A Mazur & A Scalbert (2005) Polyphenols and prevention of cardiovascular disease. Curr Opin Lipidol 16, 77–84.
18 G Norata , P Marchesi , S Passamonti , (2007) Anti-inflammatory and antiatherogenic effects of catechin, caffeic acid and trans-resveratrol in apoprotein E deficient mice. Atherosclerosis 191, 265–271.
19 T Hayek , B Fuhrman , J Vaya , (1997) Reduced progression of atherosclerosis in in apoprotein deficient E mice following consumption of red wine and its polyphenols quercetin or catechin is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol 17, 2744–2752.
22 JA Russell (2007) Vasopressin in septic shock. Crit Care Med 35, S609–S615.
23 KA Youdim , J McDonald , W Kalt & JA Joseph (2002) Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults (small star, filled). J Nutr Biochem 13, 282–288.
24 DX Hou , T Yanagita , T Uto , S Masuzaki & M Fujii (2005) Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure–activity relationship and molecular mechanisms involved. Biochem Pharmacol 70, 417–425.
25 C Pergola , A Rossi , P Dugo , S Cuzzocrea & L Sautebin (2006) Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract. Nitric Oxide 15, 30–39.
30 K Kobayashi , Y Saito , I Nakazawa & F Yoshizaki (2000) Screening of crude drugs for influence on amylase activity and postprandial blood glucose in mouse plasma. Biol Pharm Bull 23, 1250–1253.
33 J Watanabe , J Kawabata , H Kurihara & R Niki (1997) Isolation and identification of alpha-glucosidase inhibitors from tochu-cha (Eucommia ulmoides). Biosci Biotechnol Biochem 61, 177–178.
36 B Jayaprakasam , SK Vareed , LK Olson & MG Nair (2005) Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J Agric Food Chem 53, 28–31.
37 LC Martineau , A Couture , D Spoor , A Benhaddou-Andaloussi , C Harris , B Meddah , C Leduc , A Burt , T Vuong , P Mai Le , M Prentki , SA Bennett , JT Arnason & PS Haddad (2006) Anti-diabetic properties of the Canadian lowbush blueberry Vaccinium angustifolium Ait. Phytomedicine 13, 612–623.
38 T Tsuda , Y Ueno , T Yoshikawa , H Kojo & T Osawa (2006) Microarray profiling of gene expression in human adipocytes in response to anthocyanins. Biochem Pharmacol 71, 1184–1197.
45 P Ravicumar & C Anuradha (1999) Effect of fenugreek seeds on blood lipid peroxidation and antioxidants in diabetic rats. Phytother Res 13, 197–201.
47 ER Shanmugasundaram , G Rajeswari , K Baskaran , (1990) Use of Gymnea sylvestre leaf extract in the control of blond glucose in insulin-dependent diabetes mellitus. J Ethnopharmacol 30, 281–294.
48 RD Sharma & TC Raghuram (1990) Hypoglycemic effect of fenugreek seeds in non-insulin dependent diabetic subjects. Nutr Res 10, 731–739.
49 RD Sharma , TC Raghuram & V Dayasagar Rao (1991) Hypolipidaemic effect of fenugreek seeds. A clinical study. Phytother Res 5, 145–147.
50 S Iwata , N Nagat , A Omae , (1999) Inhibitory effect of chalcone derivatives on recombinant human aldose reductase. Biol Pharm Bull 22, 323–325.
51 M Yoshikawa , T Morikawa , T Murakami , (1999) Medicinal flowers I. Aldose reductase inhibitors and three new eudesmane-type sesquiterpenes, kikkanols A, B, and C from the flowers of Chrysanthemum indicum L. Chem Pharm Bull (Tokyo) 47, 340–345.
52 SS Lim , SH Jung , KH Shin & SR Keum (2001) Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetes rat tissues. J Pharm Pharmacol 53, 653–668.
53 JC Stoclet , T Chataigneau , M Ndiaye , (2004) Vascular protection by dietary polyphenols. Eur J Pharmacol 500, 299–313.
54 KY Chyu , SM Babbidge , X Zhayo , (2004) Differential effect of green tea-derived catechin on developing versus established atherosclerosis in apoprotein E-null mice. Circulation 109, 2448–2453.
56 JC Liu , JJ Chen , P Chan , (2003) Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 42, 1198–1205.
57 MA Rupnick , D Panigrahy , CY Zhang , (2002) Adipose trissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A 99, 10730–10735.
59 JN Fain , AK Madan , L Hiler , (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145, 2273–2282.
60 JN Losso (2003) Targeting excessive angiogenesis with functional foods and nutraceuticals. Trends Food Sci Technol 14, 455–468.
61 MH Oak , M Chataigneau , T Keravis , (2003) Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein kinase pathway. Atheroscler Thromb Vasc Biol 23, 1001–1007.
62 A Dembinska-Kiec , A Polus , B Kiec-Wilk , (2005) Proangiogenic activity of beta-carotene is coupled with the activation of endothelial cell chemotaxis. Biochim Biophys Acta 1740, 2, 222–239.
64 M Meydani (2001) Nutrition interventions in aging and age-associated disease. Ann N Y Acad Sci 928, 226–235.
65 Y Cao (2007) Angiogenesis modulates adipogenesis and obesity. J Clin Invest 117, 2362–2368.
66 M Thirunavukkarasu , SV Penumathsa , S Koneru , B Juhasz , L Zhan , H Otani , D Bagchi , DK Das & N Maulik (2007) Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 43, 720–729.
67 UN Das (1999) GLUT-4, tumor necrosis factor, essential fatty acids and daf-genes and their role in insulin resistance and non-insulin dependent diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 60, 13–20.
68 JØ Moskaug , H Carlsen , M Myhrstad & R Blomhoff (2004) Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech Ageing Dev 125, 315–324.
69 MA Abahusian , J Wright , JWT Dickerson & EB Vol (1993) Retinol, α-tocopherol and carotenoids in diabetes. Eur J Clin Nutr 53, 630–635.
72 L Sargeant , K Khaw , S Bingham , (2001) Fruit and vegetable intake and population glycosylated haemoglobin levels: the EPIC-Norfolk Study. Eur J Clin Nutr 55, 342–348.
73 ES Ford , JC Will , BA Bowman & KMV Narayan (1999) Diabetes mellitus and serum carotenoids. Findings from the Third National Health and Nutritional examination. Am J Epidemiol 149, 168–176.
74 J Montonen , P Knekt , T Harkanen , R Jarvinen , M Heliovaara , A Aromaa & A Reunaner (2005) Dietary patterns and the incidence of type 2 diabetes. Am J Epidemiol 161, 219–227.
76 L Wang , S Liu , AD Pradhan , (2006) Plasma lycopene, other carotenoids and the risk of type 2 diabetes in women. Am J Epidemiol 164, 576–585.
77 S Liu , U Ajani , C Chae , C Hennekens , (1999) Long-term beta-carotene supplementation and risk of type-2 diabetes mellitus: a randomized, controlled trial. JAMA 282, 1073–1075.